{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T15:26:16Z","timestamp":1778599576626,"version":"3.51.4"},"reference-count":150,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2021,1,20]],"date-time":"2021-01-20T00:00:00Z","timestamp":1611100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,20]],"date-time":"2021-01-20T00:00:00Z","timestamp":1611100800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Neurosci"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1007\/s12031-020-01774-7","type":"journal-article","created":{"date-parts":[[2021,1,20]],"date-time":"2021-01-20T14:04:36Z","timestamp":1611151476000},"page":"2022-2034","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Integrating Endocannabinoid Signalling In Depression"],"prefix":"10.1007","volume":"71","author":[{"given":"Tarapati","family":"Rana","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0993-7708","authenticated-orcid":false,"given":"Tapan","family":"Behl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aayush","family":"Sehgal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vineet","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sukhbir","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravinder","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona","family":"Bungau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,20]]},"reference":[{"key":"1774_CR1","first-page":"217","volume":"59","author":"P Adamczyk","year":"2008","unstructured":"Adamczyk P, Golda A, McCreary AC, Filip M, Przegalinski E (2008) Activation of endocannabinoid transmission induces antidepressant-like effects in rats. J Physiol Pharmacol 59:217\u2013228","journal-title":"J Physiol Pharmacol"},{"key":"1774_CR2","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S0301-0082(02)00080-1","volume":"68","author":"BE Alger","year":"2002","unstructured":"Alger BE (2002) Retrograde signaling in the regulation of synaptic transmission: focus on endocannabinoids. Prog Neurobiol 68:247\u2013286. https:\/\/doi.org\/10.1016\/S0301-0082(02)00080-1","journal-title":"Prog Neurobiol"},{"key":"1774_CR3","doi-asserted-by":"publisher","unstructured":"American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders, 5th ed., A.P. Publishing: Arlington. https:\/\/doi.org\/10.1176\/appi.books.9780890425596.","DOI":"10.1176\/appi.books.9780890425596"},{"key":"1774_CR4","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/S0079-6123(02)36037-0","volume":"136","author":"V Arango","year":"2002","unstructured":"Arango V et al (2002) Serotonin brain circuits involved in major depression and suicide. Prog Brain Res 136:443\u2013453","journal-title":"Prog Brain Res"},{"key":"1774_CR5","doi-asserted-by":"crossref","unstructured":"Ashton JC, Dowie MJ, Glass M (2017) The endocannabinoid system and human brain functions: insight from memory, motor, and mood pathologies, The endocananbinoid system: genetics, biochemistry, brain disorders, and therapy, Cambridge (Massachusetts), USA. 115\u2013186.","DOI":"10.1016\/B978-0-12-809666-6.00005-8"},{"key":"1774_CR6","doi-asserted-by":"crossref","unstructured":"Atkinson DL, Abbott JK (2018) Cannabinoids and the brain: the effects of endogenous and exogenous cannabinoids on brain systems and function. The complex connection between cannabis and schizophrenia. Cambridge (Massachusetts), USA. 37\u201374.","DOI":"10.1016\/B978-0-12-804791-0.00003-3"},{"key":"1774_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.tips.2005.11.003","volume":"27","author":"D Baker","year":"2006","unstructured":"Baker D, Pryce G, Davis WL, Hiley CR (2006) In silico patent searching reveals a new cannabinoid receptor. Trends Pharmacol Sci 27:1\u20134. https:\/\/doi.org\/10.1016\/j.tips.2005.11.003","journal-title":"Trends Pharmacol Sci"},{"key":"1774_CR8","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1517\/14728222.12.11.1347","volume":"12","author":"FR Bambico","year":"2008","unstructured":"Bambico FR, Gobbi G (2008) The cannabinoid CB1 receptor and the endocannabinoid anandamide: possible antidepressant targets. Expert Opin Ther Targets 12:1347\u20131366","journal-title":"Expert Opin Ther Targets"},{"key":"1774_CR9","doi-asserted-by":"publisher","first-page":"11700","DOI":"10.1523\/JNEUROSCI.1636-07.2007","volume":"27","author":"FR Bambico","year":"2007","unstructured":"Bambico FR, Katz N, Debonnel G, Gobbi G (2007) Cannabinoids elicit antidepressant-like behavior and activate serotonergic neurons through the medial prefrontal cortex. J Neurosci 27:11700\u201311711","journal-title":"J Neurosci"},{"key":"1774_CR10","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/sj.tpj.6500301","volume":"5","author":"FJ Barrero","year":"2005","unstructured":"Barrero FJ et al (2005) Depression in Parkinson\u2019s disease is related to a genetic polymorphism of the cannabinoid receptor gene (CNR1). Pharmacogenomics J 5:135\u2013141","journal-title":"Pharmacogenomics J"},{"key":"1774_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.abb.2013.05.003","volume":"536","author":"J Barricklow","year":"2013","unstructured":"Barricklow J, Blatnik M (2013) 2-Arachidonoylglycerol is a substrate for butyrylcholinesterase: a potential mechanism for extracellular endocannabinoid regulation. Arch Biochem Biophys 536:1\u20135","journal-title":"Arch Biochem Biophys"},{"key":"1774_CR12","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/89953","volume":"7","author":"S Batkai","year":"2001","unstructured":"Batkai S, Jarai Z, Wagner JA, Goparaju SK, Varga K, Liu J et al (2001) Endocannabinoids acting at vascular CB1 receptors mediate the vasodilated state in advanced liver cirrhosis. Nat Med 7:827\u2013832. https:\/\/doi.org\/10.1038\/89953","journal-title":"Nat Med"},{"key":"1774_CR13","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1097\/01.wco.0000194141.56429.3c","volume":"18","author":"A Bechara","year":"2005","unstructured":"Bechara A, Van Der Linden M (2005) Decision-making and impulse control after frontal lobe injuries. Curr Opin Neurol 18:734\u2013739","journal-title":"Curr Opin Neurol"},{"key":"1774_CR14","doi-asserted-by":"publisher","first-page":"11136","DOI":"10.1523\/JNEUROSCI.23-35-11136.2003","volume":"23","author":"C Benito","year":"2003","unstructured":"Benito C, Nunez E, Tolon RM, Carrier EJ, Rabano A, Hillard CJ et al (2003) Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer\u2019s disease brains. J Neurosci 23:11136\u201311141. https:\/\/doi.org\/10.1523\/JNEUROSCI.23-35-11136.2003","journal-title":"J Neurosci"},{"key":"1774_CR15","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1124\/pr.112.006387","volume":"65","author":"JL Blankman","year":"2013","unstructured":"Blankman JL, Cravatt BF (2013) Chemical probes of endocannabinoid metabolism. Pharmacol Rev 65:849\u2013871","journal-title":"Pharmacol Rev"},{"key":"1774_CR16","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/j.chembiol.2007.11.006","volume":"14","author":"JL Blankman","year":"2007","unstructured":"Blankman JL, Simon GM, Cravatt BF (2007) A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol. Chem Biol 14:1347\u20131356","journal-title":"Chem Biol"},{"key":"1774_CR17","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/j.biopsych.2006.12.001","volume":"62","author":"M Bortolato","year":"2007","unstructured":"Bortolato M, Mangieri RA, Fu J, Kim JH, Arguello O, Duranti A et al (2007) Antidepressant-like activity of the fatty acid amide hydrolase inhibitor URB597 in a rat model of chronic mild stress. Biol Psychiatry 62:1103\u20131110","journal-title":"Biol Psychiatry"},{"key":"1774_CR18","doi-asserted-by":"publisher","first-page":"e3","DOI":"10.1017\/S1462399409000957","volume":"11","author":"GA Cabral","year":"2009","unstructured":"Cabral GA, Griffin-Thomas L (2009) Emerging role of the cannabinoid receptor CB2 in immune regulation: therapeutic prospects for neuroinflammation. Expert Rev Mol Med 11:e3. https:\/\/doi.org\/10.1017\/S1462399409000957","journal-title":"Expert Rev Mol Med"},{"key":"1774_CR19","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/sj.bjp.0707584","volume":"153","author":"GA Cabral","year":"2008","unstructured":"Cabral GA, Raborn ES, Griffin L, Dennis J, Marciano-Cabral F (2008) CB2 receptors in the brain: role in central immune function. Br J Pharmacol 153:240\u2013251. https:\/\/doi.org\/10.1038\/sj.bjp.0707584","journal-title":"Br J Pharmacol"},{"key":"1774_CR20","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.neuron.2012.09.020","volume":"76","author":"PE Castillo","year":"2012","unstructured":"Castillo PE, Younts TJ, Chavez AE, Hashimotodani Y (2012) Endocannabinoid signaling and synaptic function. Neuron 76:70\u201381. https:\/\/doi.org\/10.1016\/j.neuron.2012.09.020","journal-title":"Neuron"},{"key":"1774_CR21","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1084\/jem.20150225","volume":"212","author":"N Chiang","year":"2015","unstructured":"Chiang N, Dalli J, Colas RA, Serhan CN (2015) Identification of resolvin D2 receptor mediating resolution of infections and organ protection. J Exp Med 212:1203\u20131217. https:\/\/doi.org\/10.1084\/jem.20150225","journal-title":"J Exp Med"},{"key":"1774_CR22","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/384083a0","volume":"384","author":"BF Cravatt","year":"1996","unstructured":"Cravatt BF, Giang DK, Mayfield SP, Boger DL, Lerner RA, Gilula NB (1996) Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature 384:83\u201387","journal-title":"Nature"},{"key":"1774_CR23","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0306-4522(00)00552-2","volume":"103","author":"B Dean","year":"2001","unstructured":"Dean B et al (2001) Studies on [3H] CP-55940 binding in the human central nervous system: regional specific changes in density of CB-1 receptors associated withschizophrenia and cannabisuse. Neurosci 103:9\u201315","journal-title":"Neurosci"},{"key":"1774_CR24","doi-asserted-by":"publisher","first-page":"370","DOI":"10.3389\/fphar.2016.00370","volume":"7","author":"DG Deutsch","year":"2016","unstructured":"Deutsch DG (2016) A personal retrospective: elevating anandamide (AEA) by Targeting Fatty Acid Amide Hydrolase (FAAH) and the Fatty Acid Binding Proteins (FABPs). Front Pharmacol 7:370","journal-title":"Front Pharmacol"},{"key":"1774_CR25","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1126\/science.1470919","volume":"258","author":"WA Devane","year":"1992","unstructured":"Devane WA et al (1992) Isolation and structure of a brain constituent that binds to the CB receptor. Science 258:1946\u20131949","journal-title":"Science"},{"key":"1774_CR26","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.phrs.2009.02.010","volume":"60","author":"V Di Marzo","year":"2009","unstructured":"Di Marzo V (2009) The endocannabinoid system: its general strategy of action, tools for its pharmacological manipulation and potential therapeutic exploitation. Pharmacol Res 60:77\u201384. https:\/\/doi.org\/10.1016\/j.phrs.2009.02.010","journal-title":"Pharmacol Res"},{"key":"1774_CR27","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/372686a0","volume":"372","author":"V Di Marzo","year":"1994","unstructured":"Di Marzo V, Fontana A, Cadas H, Schinelli S, Cimino G, Schwartz JC, Piomelli D (1994) Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature 372:686\u2013691","journal-title":"Nature"},{"key":"1774_CR28","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S0166-2236(98)01283-1","volume":"21","author":"V Di Marzo","year":"1998","unstructured":"Di Marzo V, Melck D, Bisogno T, De Petrocellis L (1998) Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action. Trends Neurosci 21:521\u2013528. https:\/\/doi.org\/10.1016\/S0166-2236(98)01283-1","journal-title":"Trends Neurosci"},{"key":"1774_CR29","doi-asserted-by":"publisher","first-page":"10819","DOI":"10.1073\/pnas.152334899","volume":"99","author":"TP Dinh","year":"2002","unstructured":"Dinh TP, Carpenter D, Leslie FM, Freund TF, Katona I, Sensi SL et al (2002) Brain monoglyceride lipase participating in endocannabinoid inactivation. Proc Natl Acad Sci U S A 99:10819\u2013108124. https:\/\/doi.org\/10.1073\/pnas.152334899","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1774_CR30","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S0079-6123(00)26027-5","volume":"126","author":"WC Drevets","year":"2000","unstructured":"Drevets WC (2000) Functional anatomical abnormalities in limbic and prefrontal cortical structures in major depression. Prog Brain Res 126:413\u2013431","journal-title":"Prog Brain Res"},{"key":"1774_CR31","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/S0924-977X(02)00102-5","volume":"12","author":"WC Drevets","year":"2002","unstructured":"Drevets WC et al (2002) Functional anatomical correlates of antidepressant drug treatment assessed using PET measures of regional glucose metabolism. Eur Neuropsychopharmacol 12:527\u2013544","journal-title":"Eur Neuropsychopharmacol"},{"key":"1774_CR32","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/S0306-4522(03)00145-3","volume":"119","author":"M Egertova","year":"2003","unstructured":"Egertova M, Cravatt BF, Elphick MR (2003) Comparative analysis of fatty acid amide hydrolase and cb(1) cannabinoid receptor expression in the mouse brain: evidence of a widespread role for fatty acid amide hydrolase in regulation of endocannabinoid signaling. Neuroscience 119:481\u2013496. https:\/\/doi.org\/10.1016\/S0306-4522(03)00145-3","journal-title":"Neuroscience"},{"key":"1774_CR33","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.pbb.2012.05.009","volume":"102","author":"MM Elbatsh","year":"2012","unstructured":"Elbatsh MM, Moklas MAA, Marsden CA, Kendall DA (2012) Antidepressant-like effects of \u03949-tetrahydrocannabinol and rimonabant in the olfactory bulbectomised rat model of depression. Pharmacol Biochem Behav 102:357\u2013365","journal-title":"Pharmacol Biochem Behav"},{"key":"1774_CR34","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/S0091-3057(96)00426-1","volume":"56","author":"HM Emrich","year":"1997","unstructured":"Emrich HM et al (1997) Towards a CB hypothesis of schizophrenia: cognitive impairments due to dysregulation of the endogenous CB system. Pharmacol Biochem Behav 56:803\u2013807","journal-title":"Pharmacol Biochem Behav"},{"key":"1774_CR35","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.phrs.2017.01.008","volume":"117","author":"B Farran","year":"2017","unstructured":"Farran B (2017) An update on the physiological and therapeutic relevance of GPCR oligomers. Pharmacol Res 117:303\u2013327. https:\/\/doi.org\/10.1016\/j.phrs.2017.01.008","journal-title":"Pharmacol Res"},{"key":"1774_CR36","doi-asserted-by":"publisher","first-page":"17078","DOI":"10.3390\/molecules191117078","volume":"19","author":"F Fezza","year":"2014","unstructured":"Fezza F, Bari M, Florio R, Talamonti E, Feole M, Maccarrone M (2014) Endocannabinoids, related compounds and their metabolic routes. Molecules 19:17078\u201317106. https:\/\/doi.org\/10.3390\/molecules191117078","journal-title":"Molecules"},{"key":"1774_CR37","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.prostaglandins.2013.02.002","volume":"102","author":"BM Fonseca","year":"2013","unstructured":"Fonseca BM, Costa MA, Almada M, Correia-da-Silva G, Teixeira NA (2013) Endogenous cannabinoids revisited: a biochemistry perspective. Prostaglandins Other Lipid Mediat 102:13\u201330","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"1774_CR38","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1152\/physrev.00004.2003","volume":"83","author":"TF Freund","year":"2003","unstructured":"Freund TF, Katona I, Piomelli D (2003) Role of endogenous cannabinoids in synaptic signaling. Physiol Rev 83:1017\u20131066","journal-title":"Physiol Rev"},{"key":"1774_CR39","doi-asserted-by":"crossref","unstructured":"Fride E, Sanudo-Pena C (2002) Cannabinoids and endocannabinoids: behavioral and developmental aspects, In The Biology of Marijuana (Onaivi, E., ed.), Harwood Academic.","DOI":"10.1201\/9780203219133.ch6"},{"key":"1774_CR40","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/j.1432-1033.1995.tb20780.x","volume":"232","author":"S Galiegue","year":"1995","unstructured":"Galiegue S, Mary S, Marchand J, Dussossoy D, Carriere D, Carayon P et al (1995) Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur J Biochem 232:54\u201361. https:\/\/doi.org\/10.1111\/j.1432-1033.1995.tb20780.x","journal-title":"Eur J Biochem"},{"key":"1774_CR41","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1007\/s13311-018-0610-y","volume":"15","author":"MS Garcia-Gutierrez","year":"2018","unstructured":"Garcia-Gutierrez MS, Navarrete F, Navarro G, Reyes-Resina I, Franco R, Lanciego JL et al (2018) Alterations in Gene and Protein Expression of Cannabinoid CB2 and GPR55 Receptors in the Dorsolateral Prefrontal Cortex of Suicide Victims. Neurotherapeutics 15:796\u2013806. https:\/\/doi.org\/10.1007\/s13311-018-0610-y","journal-title":"Neurotherapeutics"},{"key":"1774_CR42","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1111\/j.1476-5381.2010.00819.x","volume":"160","author":"MS Garcia-Gutierrez","year":"2010","unstructured":"Garcia-Gutierrez MS, Perez-Ortiz JM, Gutierrez-Adan A, Manzanares J (2010) Depression-resistant endophenotype in mice overexpressing cannabinoid CB(2) receptors. Br J Pharmacol 160:1773\u20131784. https:\/\/doi.org\/10.1111\/j.1476-5381.2010.00819.x","journal-title":"Br J Pharmacol"},{"key":"1774_CR43","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1038\/sj.npp.1300558","volume":"29","author":"A Giuffrida","year":"2004","unstructured":"Giuffrida A et al (2004) Cerebrospinal anandamide levels are elevated in acute schizophrenia and are inversely correlated with psychotic symptoms. Neuropsychopharmacology 29:2108\u20132114","journal-title":"Neuropsychopharmacology"},{"key":"1774_CR44","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/S0306-4522(96)00428-9","volume":"77","author":"M Glass","year":"1997","unstructured":"Glass M, Dragunow M, Faull RL (1997) Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain. Neuroscience 77:299\u2013318. https:\/\/doi.org\/10.1016\/S0306-4522(96)00428-9","journal-title":"Neuroscience"},{"key":"1774_CR45","doi-asserted-by":"publisher","first-page":"18620","DOI":"10.1073\/pnas.0509591102","volume":"102","author":"G Gobbi","year":"2005","unstructured":"Gobbi G et al (2005) Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis. Proc Natl Acad Sci U S A 102:18620\u201318625","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1774_CR46","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.brainres.2005.11.035","volume":"1071","author":"JP Gong","year":"2006","unstructured":"Gong JP, Onaivi ES, Ishiguro H, Liu QR, Tagliaferro PA, Brusco A et al (2006) Cannabinoid CB2 receptors: immunohistochemical localization in rat brain. Brain Res 1071:10\u201323. https:\/\/doi.org\/10.1016\/j.brainres.2005.11.035","journal-title":"Brain Res"},{"key":"1774_CR47","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1038\/s41598-018-20895-z","volume":"8","author":"G Griebel","year":"2018","unstructured":"Griebel G, Stemmelin J, Lopez-Grancha M, Fauchey V, Slowinski F, Pichat P et al (2018) The selective reversible FAAH inhibitor, SSR411298, restores the development of maladaptive behaviors to acute and chronic stress in rodents. Sci Rep 8:2416","journal-title":"Sci Rep"},{"key":"1774_CR48","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.biopsych.2004.10.032","volume":"57","author":"G Griebel","year":"2005","unstructured":"Griebel G, Stemmelin J, Scatton B (2005) Effects of the cannabinoid CB1 receptor antagonist rimonabant in models of emotional reactivity in rodents. Biol Psychiatry 57:261\u2013267","journal-title":"Biol Psychiatry"},{"key":"1774_CR49","doi-asserted-by":"publisher","first-page":"403","DOI":"10.2174\/187152709789824660","volume":"8","author":"J Guindon","year":"2009","unstructured":"Guindon J, Hohmann AG (2009) The endocannabinoid system and pain. CNS Neurol Disord Drug Targets 8:403\u2013421. https:\/\/doi.org\/10.2174\/187152709789824660","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"1774_CR50","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s001090000177","volume":"78","author":"M Guzman","year":"2001","unstructured":"Guzman M, Sanchez C, Galve-Roperh I (2001) Control of the cell survival\/death decision by cannabinoids. J Mol Med (Berl) 78:613\u2013625. https:\/\/doi.org\/10.1007\/s001090000177","journal-title":"J Mol Med (Berl)"},{"key":"1774_CR51","doi-asserted-by":"publisher","first-page":"31","DOI":"10.2131\/jts.36.31","volume":"36","author":"T Hayase","year":"2011","unstructured":"Hayase T (2011) Depression-related anhedonic behaviors caused by immobilization stress: a comparison with nicotine-induced depression-like behavioral alterations and effects of nicotine and\/or \u201cantidepressant\u201d drugs. J Toxicol Sci 36:31\u201341","journal-title":"J Toxicol Sci"},{"key":"1774_CR52","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1146\/annurev.physiol.010908.163149","volume":"71","author":"BD Heifets","year":"2009","unstructured":"Heifets BD, Castillo PE (2009) Endocannabinoid signaling and long-term synaptic plasticity. Ann Rev Physiol 71:283\u2013306. https:\/\/doi.org\/10.1146\/annurev.physiol.010908.163149","journal-title":"Ann Rev Physiol"},{"key":"1774_CR53","doi-asserted-by":"publisher","first-page":"9449","DOI":"10.1523\/JNEUROSCI.2078-05.2005","volume":"25","author":"T Heinbockel","year":"2005","unstructured":"Heinbockel T, Brager DH, Reich CG, Zhao J, Muralidharan S, Alger BE et al (2005) Endocannabinoid signaling dynamics probed with optical tools. J Neurosci 25:9449\u20139459. https:\/\/doi.org\/10.1523\/JNEUROSCI.2078-05.2005","journal-title":"J Neurosci"},{"key":"1774_CR54","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1073\/pnas.87.5.1932","volume":"87","author":"M Herkenham","year":"1990","unstructured":"Herkenham M, Lynn AB, Little MD, Johnson MR, Melvin LS, De Costa BR et al (1990) Cannabinoid receptor localization in brain. Proc Natl Acad Sci USA 87:1932\u20131936","journal-title":"Proc Natl Acad Sci USA"},{"key":"1774_CR55","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s00213-007-1033-3","volume":"198","author":"SA Hesketh","year":"2008","unstructured":"Hesketh SA, Brennan AK, Jessop DS, Finn DP (2008) Effects of chronic treatment with citalopram on cannabinoid and opioid receptor-mediated G-protein coupling in discrete rat brain regions. Psychopharmacology 198:29\u201336","journal-title":"Psychopharmacology"},{"key":"1774_CR56","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.psyneuen.2011.09.017","volume":"37","author":"E Heyman","year":"2012","unstructured":"Heyman E, Gamelin FX, Goekint M, Piscitelli F, Roelands B, Leclair E et al (2012) Intense exercise increases circulating endocannabinoid and BDNF levels in humans-possible implications for reward and depression. Psychoneuroendocrinology 37:844\u2013851. https:\/\/doi.org\/10.1016\/j.psyneuen.2011.09.017","journal-title":"Psychoneuroendocrinology"},{"key":"1774_CR57","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.jad.2011.12.036","volume":"140","author":"BH Hidaka","year":"2012","unstructured":"Hidaka BH (2012) Depression as a disease of modernity: explanations for increasing prevalence. J Affect Disord 140:205\u2013214. https:\/\/doi.org\/10.1016\/j.jad.2011.12.036","journal-title":"J Affect Disord"},{"key":"1774_CR58","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.1111\/j.1471-4159.2008.05567.x","volume":"106","author":"MN Hill","year":"2008","unstructured":"Hill MN, Carrier EJ, McLaughlin RJ, Morrish AC, Meier SE, Hillard CJ et al (2008) Regional alterations in the endocannabinoid system in an animal model of depression: effects of concurrent antidepressant treatment. J Neurochem 106:2322\u20132336","journal-title":"J Neurochem"},{"key":"1774_CR59","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/sj.npp.1300601","volume":"30","author":"MN Hill","year":"2005","unstructured":"Hill MN et al (2005) Downregulation of endocannabinoid signaling in the hippocampus following chronic unpredictable stress. Neuropsychopharmacology 30:508\u2013515","journal-title":"Neuropsychopharmacology"},{"key":"1774_CR60","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.euroneuro.2005.03.003","volume":"15","author":"MN Hill","year":"2005","unstructured":"Hill MN, Gorzalka BB (2005) Pharmacological enhancement of cannabinoid CB1 receptor activity elicits an antidepressant-like response in the rat forced swim test. Eur Neuropsychopharmacol 15:593\u2013599","journal-title":"Eur Neuropsychopharmacol"},{"key":"1774_CR61","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.tips.2009.06.006","volume":"30","author":"MN Hill","year":"2009","unstructured":"Hill MN, Hillard CJ, Bambico FR, Patel S, Gorzalka BB, Gobbi G (2009) The therapeutic potential of the endocannabinoid system for the development of a novel class of antidepressants. Trends Pharmacol Sci 30:484\u2013493","journal-title":"Trends Pharmacol Sci"},{"key":"1774_CR62","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1007\/s00702-008-0131-7","volume":"115","author":"MN Hill","year":"2008","unstructured":"Hill MN, Ho W-SV, Hillard CJ, Gorzalka BB (2008) Differential effects of the antidepressants tranylcypromine and fluoxetine on limbic cannabinoid receptor binding and endocannabinoid contents. J Neural Transm 115:1673\u20131679","journal-title":"J Neural Transm"},{"key":"1774_CR63","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.1038\/sj.npp.1301092","volume":"31","author":"MN Hill","year":"2006","unstructured":"Hill MN, Ho W-SV, Sinopoli KJ, Viau V, Hillard CJ, Gorzalka BB (2006) Involvement of the endocannabinoid system in the ability of long-term tricyclic antidepressant treatment to suppress stress-induced activation of the hypothalamic-pituitary-adrenal axis. Neuropsychopharmacology 31:2591\u20132599","journal-title":"Neuropsychopharmacology"},{"key":"1774_CR64","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/j.psyneuen.2009.03.013","volume":"34","author":"MN Hill","year":"2009","unstructured":"Hill MN, Miller GE, Carrier EJ, Gorzalka BB, Hillard CJ (2009) Circulating endocannabinoids and N-acyl ethanolamines are differentially regulated in major depression and following exposure to social stress. Psychoneuroendocrinology 34:1257\u20131262","journal-title":"Psychoneuroendocrinology"},{"key":"1774_CR65","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1055\/s-2007-993211","volume":"41","author":"MN Hill","year":"2008","unstructured":"Hill MN, Miller GE, Ho WS, Gorzalka BB, Hillard CJ (2008) Serum endocannabinoid content is altered in females with depressive disorders: a preliminary report. Pharmacopsychiatry 41:48\u201353. https:\/\/doi.org\/10.1055\/s-2007-993211","journal-title":"Pharmacopsychiatry"},{"key":"1774_CR66","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/2045-5380-3-19","volume":"3","author":"MN Hill","year":"2013","unstructured":"Hill MN, Patel S (2013) Translational evidence for the involvement of the endocannabinoid system in stress-related psychiatric illnesses. Biol Mood Anxiety Disord 3:19","journal-title":"Biol Mood Anxiety Disord"},{"key":"1774_CR67","doi-asserted-by":"publisher","first-page":"3795","DOI":"10.2174\/13816128113196660735","volume":"20","author":"CJ Hillard","year":"2014","unstructured":"Hillard CJ, Liu QS (2014) Endocannabinoid signaling in the etiology and treatment of major depressive illness. Curr Pharm Des 20:3795\u20133811","journal-title":"Curr Pharm Des"},{"key":"1774_CR68","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1038\/nature03658","volume":"435","author":"AG Hohmann","year":"2005","unstructured":"Hohmann AG, Suplita RL, Bolton NM, Neely MH, Fegley D, Mangieri R et al (2005) An endocannabinoid mechanism for stress-induced analgesia. Nature 435:1108\u20131112. https:\/\/doi.org\/10.1038\/nature03658","journal-title":"Nature"},{"key":"1774_CR69","first-page":"619","volume":"68\u201369","author":"AC Howlett","year":"2002","unstructured":"Howlett AC (2002) The cannabinoid receptors Prost Lipid Mediat 68\u201369:619\u2013631","journal-title":"The cannabinoid receptors Prost Lipid Mediat"},{"key":"1774_CR70","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1124\/pr.54.2.161","volume":"54","author":"AC Howlett","year":"2002","unstructured":"Howlett AC, Barth F, Bonner TI, Cabral G, Casellas WA, Devane CC et al (2002) International Union of Pharmacology. XXVII. Classification of cannabinoid receptors Pharmacol Rev 54:161\u2013202. https:\/\/doi.org\/10.1124\/pr.54.2.161","journal-title":"Classification of cannabinoid receptors Pharmacol Rev"},{"key":"1774_CR71","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/0166-2236(90)90124-S","volume":"13","author":"AC Howlett","year":"1990","unstructured":"Howlett AC, Bidaut-Russell M, Devane WA, Melvin LS, Johnson MR, Herkenham M (1990) The cannabinoid receptor: biochemical, anatomical and behavioral characterization. Trends Neurosci 13:420\u2013423. https:\/\/doi.org\/10.1016\/0166-2236(90)90124-S","journal-title":"Trends Neurosci"},{"key":"1774_CR72","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.pain.2009.02.018","volume":"143","author":"B Hu","year":"2009","unstructured":"Hu B, Doods H, Treede RD, Ceci A (2009) Depression-like behaviour in rats with mononeuropathy is reduced by the CB2-selective agonist GW405833. Pain 143:206\u2013212","journal-title":"Pain"},{"key":"1774_CR73","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/sj.mp.4001376","volume":"9","author":"BL Hungund","year":"2004","unstructured":"Hungund BL et al (2004) Upregulation of CB1 receptors and agonist stimulated [35S]GTPgS binding in the prefrontal cortex of depressed suicide victims. Mol Psychiatry 9:184\u2013190","journal-title":"Mol Psychiatry"},{"key":"1774_CR74","doi-asserted-by":"publisher","first-page":"3093","DOI":"10.1073\/pnas.0409888102","volume":"102","author":"MM Ibrahim","year":"2005","unstructured":"Ibrahim MM, Porreca F, Lai J, Albrecht PJ, Rice FL, Khodorova A et al (2005) CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids. Proc Natl Acad Sci USA 102:3093\u20133098","journal-title":"Proc Natl Acad Sci USA"},{"key":"1774_CR75","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1007\/BF00401256","volume":"11","author":"H Isbell","year":"1967","unstructured":"Isbell H, Gorodetzsky CW, Jasinski D, Clausseln U, von Spulak F, Korte F (1967) Effects of (\u2014) delta-9-trans-tetrahydrocannabinol in man. Psychopharmacologia 11:184\u2013188","journal-title":"Psychopharmacologia"},{"key":"1774_CR76","doi-asserted-by":"publisher","first-page":"6339","DOI":"10.1073\/pnas.1103566108","volume":"108","author":"AA Izzo","year":"2011","unstructured":"Izzo AA, Deutsch DG (2011) Unique pathway for an andamide synthesis and liver regeneration. Proc Natl Acad Sci U S A 108:6339\u20136340","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1774_CR77","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1152\/physrev.00019.2008","volume":"89","author":"M Kano","year":"2009","unstructured":"Kano M, Ohno-Shosaku T, Hashimotodani Y, Uchigashima M, Watanabe M (2009) Endocannabinoid-mediated control of synaptic transmission. Physiol Rev 89:309\u2013380. https:\/\/doi.org\/10.1152\/physrev.00019.2008","journal-title":"Physiol Rev"},{"key":"1774_CR78","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1146\/annurev-neuro-062111-150420","volume":"35","author":"I Katona","year":"2012","unstructured":"Katona I, Freund TF (2012) Multiple functions of endocannabinoid signaling in the brain. Annu Rev Neurosci 35:529\u2013558. https:\/\/doi.org\/10.1146\/annurev-neuro-062111-150420","journal-title":"Annu Rev Neurosci"},{"key":"1774_CR79","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1097\/JCP.0000000000000581","volume":"36","author":"MA Katzman","year":"2016","unstructured":"Katzman MA, Furtado M, Anand L (2016) Targeting the Endocannabinoid System in Psychiatric Illness. J Clin Psychopharmacol 36:691\u2013703. https:\/\/doi.org\/10.1097\/JCP.0000000000000581","journal-title":"J Clin Psychopharmacol"},{"key":"1774_CR80","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1007\/s00702-007-0660-5","volume":"114","author":"D Koethe","year":"2007","unstructured":"Koethe D, Llenos IC, Dulay JR, Hoyer C, Torrey EF, Leweke FM et al (2007) Expression of CB1 cannabinoid receptor in the anterior cingulate cortex in schizophrenia, bipolar disorder, and major depression. J Neural Transm 114:1055\u20131063","journal-title":"J Neural Transm"},{"key":"1774_CR81","doi-asserted-by":"publisher","first-page":"33744","DOI":"10.1074\/jbc.M007088200","volume":"275","author":"KR Kozak","year":"2000","unstructured":"Kozak KR, Rowlinson SW, Marnett LJ (2000) Oxygenation of the endocannabinoid, 2-arachidonylglycerol, to glyceryl prostaglandins by cyclooxygenase-2. J Biol Chem 275:33744\u201333749","journal-title":"J Biol Chem"},{"key":"1774_CR82","doi-asserted-by":"publisher","first-page":"13","DOI":"10.2174\/1574889809666140307115532","volume":"9","author":"J Kucerova","year":"2014","unstructured":"Kucerova J, Tabiova K, Drago F, Micale V (2014) Therapeutic potential of cannabinoids in schizophrenia. Recent Pat CNS Drug Discov 9:13\u201325","journal-title":"Recent Pat CNS Drug Discov"},{"key":"1774_CR83","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S1734-1140(09)70025-8","volume":"61","author":"CE Leite","year":"2009","unstructured":"Leite CE, Mocelin CA, Petersen GO, Leal MB, Thiesen FV (2009) Rimonabant: an antagonist drug of the endocannabinoid system for the treatment of obesity. Pharmacol Rep 61:217\u2013224","journal-title":"Pharmacol Rep"},{"key":"1774_CR84","doi-asserted-by":"publisher","first-page":"17410","DOI":"10.1038\/s41598-017-17796-y","volume":"7","author":"QR Liu","year":"2017","unstructured":"Liu QR, Canseco-Alba A, Zhang HY, Tagliaferro P, Chung M, Dennis E et al (2017) Cannabinoid type 2 receptors in dopamine neurons inhibits psychomotor behaviors, alters anxiety, depression and alcohol preference. Sci Rep 7:17410. https:\/\/doi.org\/10.1038\/s41598-017-17796-y","journal-title":"Sci Rep"},{"key":"1774_CR85","doi-asserted-by":"crossref","unstructured":"Lovinger D (2008) \u201cPresynaptic modulation by endocannabinoids\u201d, in: Pharmacology of Neurotransmitter Release, Handbook of Experimental Pharmacology (Berlin: Springer, Heidelberg) 435\u2013477.","DOI":"10.1007\/978-3-540-74805-2_14"},{"key":"1774_CR86","doi-asserted-by":"publisher","first-page":"257","DOI":"10.3389\/fphar.2016.00257","volume":"7","author":"N Malek","year":"2016","unstructured":"Malek N, Starowicz K (2016) Dual-acting compounds targeting endocannabinoid and endovanilloid systems-a novel treatment option for chronic pain management. Front Pharmacol 7:257","journal-title":"Front Pharmacol"},{"key":"1774_CR87","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/87865","volume":"7","author":"HK Manji","year":"2001","unstructured":"Manji HK et al (2001) The cellular neurobiology of depression. Nat Med 7:541\u2013547","journal-title":"Nat Med"},{"key":"1774_CR88","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1038\/nrn1220","volume":"4","author":"JJ Mann","year":"2003","unstructured":"Mann JJ (2003) Neurobiology of suicidal behavior. Nat Rev Neurosci 4:819\u2013828","journal-title":"Nat Rev Neurosci"},{"key":"1774_CR89","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/BF03033223","volume":"6","author":"J Manzanares","year":"2004","unstructured":"Manzanares J, Uriguen L, Rubio G, Palomo T (2004) Role of endocannabinoid system in mental diseases. Neurotox Res 6:213\u2013224. https:\/\/doi.org\/10.1007\/BF03033223","journal-title":"Neurotox Res"},{"key":"1774_CR90","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3389\/fnbeh.2011.00063","volume":"5","author":"EM Marco","year":"2011","unstructured":"Marco EM, Garcia-Gutierrez MS, Bermudez-Silva FJ, Moreira FA, Guimaraes F, Manzanares J et al (2011) Endocannabinoid system and psychiatry: in search of a neurobiological basis for detrimental and potential therapeutic effects. Front Behav Neurosci 5:63. https:\/\/doi.org\/10.3389\/fnbeh.2011.00063","journal-title":"Front Behav Neurosci"},{"key":"1774_CR91","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/sj.ijo.0803271","volume":"30","author":"I Matias","year":"2006","unstructured":"Matias I et al (2006) Endogenous cannabinoids in the brain and peripheral tissues: regulation of their levels and control of food intake. Int J Obes (Lond) 30:7\u201312","journal-title":"Int J Obes (Lond)"},{"key":"1774_CR92","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1124\/mol.109.060079","volume":"77","author":"S Mato","year":"2010","unstructured":"Mato S, Vidal R, Castro E, Diaz A, Pazos A, Valdizan EM (2010) Long-term fluoxetine treatment modulates cannabinoid type 1 receptor-mediated inhibition of adenylyl cyclase in the rat prefrontal cortex through 5-hydroxytryptamine 1 A receptor-dependent mechanisms. Mol Pharmacol 77:424\u2013434","journal-title":"Mol Pharmacol"},{"key":"1774_CR93","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/346561a0","volume":"346","author":"LA Matsuda","year":"1990","unstructured":"Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI (1990) Structure of a cannabinoid receptor and functional expression of the cloned Cdna. Nature 346:561\u2013564","journal-title":"Nature"},{"key":"1774_CR94","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1146\/annurev-psych-113011-143739","volume":"64","author":"R Mechoulam","year":"2013","unstructured":"Mechoulam R, Parker LA (2013) The endocannabinoid system and the brain. Annu Rev Psychol 64:21\u201347. https:\/\/doi.org\/10.1146\/annurev-psych-113011-143739","journal-title":"Annu Rev Psychol"},{"key":"1774_CR95","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1249\/MSS.0000000000002006","volume":"51","author":"JD Meyer","year":"2019","unstructured":"Meyer JD, Crombie KM, Cook DB, Hillard CJ, Koltyn KF (2019) Serum Endocannabinoid and Mood Changes after Exercise in Major Depressive Disorder. Med Sci Sports Exerc 51:1909\u20131917. https:\/\/doi.org\/10.1249\/MSS.0000000000002006","journal-title":"Med Sci Sports Exerc"},{"key":"1774_CR96","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.pharmthera.2012.12.002","volume":"138","author":"V Micale","year":"2013","unstructured":"Micale V, Di Marzo V, Sulcova A, Wotjak CT, Drago F (2013) Endocannabinoid system and mood disorders: priming a target for new therapies. Pharmacol Ther 138:18\u201337","journal-title":"Pharmacol Ther"},{"key":"1774_CR97","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ejphar.2004.02.034","volume":"489","author":"FM Mo","year":"2004","unstructured":"Mo FM, Offertaler L, Kunos G (2004) Atypical cannabinoid stimulates endothelial cell migration via a Gi\/Go-coupled receptor distinct from CB1, CB2 or EDG-1. Eur J Pharmacol 489:21\u201327","journal-title":"Eur J Pharmacol"},{"key":"1774_CR98","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1089\/can.2017.0036","volume":"2","author":"P Morales","year":"2017","unstructured":"Morales P, Reggio PH (2017) An Update on Non-CB1, Non-CB2 Cannabinoid Related G-Protein-Coupled Receptors. Cannabis Cannabinoid Res 2:265\u2013273. https:\/\/doi.org\/10.1089\/can.2017.0036","journal-title":"Cannabis Cannabinoid Res"},{"key":"1774_CR99","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1017\/S1461145704004080","volume":"7","author":"DA Morilak","year":"2004","unstructured":"Morilak DA, Frazer A (2004) Antidepressants and brain monoaminergic systems: a dimensional approach to understanding their behavioural effects in depression and anxiety disorders. Int J Neuropsychopharmacol 7:193\u2013218","journal-title":"Int J Neuropsychopharmacol"},{"key":"1774_CR100","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.lfs.2012.10.025","volume":"92","author":"MM Mulvihill","year":"2013","unstructured":"Mulvihill MM, Nomura DK (2013) Therapeutic potential of monoacylglycerol lipase inhibitors. Life Sci 92:492\u2013497","journal-title":"Life Sci"},{"key":"1774_CR101","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/365061a0","volume":"365","author":"S Munro","year":"1993","unstructured":"Munro S, Thomas KL, Abu-Shaar M (1993) Molecular characterization of a peripheral receptor for cannabinoids. Nature 365:61\u201365. https:\/\/doi.org\/10.1038\/365061a0","journal-title":"Nature"},{"key":"1774_CR102","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1111\/j.1460-9568.2006.04759.x","volume":"23","author":"AL Muntoni","year":"2006","unstructured":"Muntoni AL et al (2006) Cannabinoids modulate spontaneous neuronal activity and evoked inhibition of locus coeruleus noradrenergic neurons. Eur J Neurosci 23:2385\u20132394","journal-title":"Eur J Neurosci"},{"key":"1774_CR103","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.phrs.2014.04.014","volume":"87","author":"A Navarria","year":"2014","unstructured":"Navarria A, Tamburella A, Iannotti FA, Micale V, Camillieri G, Gozzo L et al (2014) The dual blocker of FAAH\/TRPV1 N-arachidonoylserotonin reverses the behavioral despair induced by stress in rats and modulates the HPA-axis. Pharmacol Res 87:151\u2013159","journal-title":"Pharmacol Res"},{"key":"1774_CR104","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s00213-005-0234-x","volume":"184","author":"AB Need","year":"2006","unstructured":"Need AB et al (2006) The relationship of in vivo central CB1 receptor occupancy to changes in cortical monoamine release and feeding elicited by CB1 receptor antagonists in rats. Psychopharmacology 184:26\u201335","journal-title":"Psychopharmacology"},{"key":"1774_CR105","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/bs.vh.2014.12.011","volume":"98","author":"S Nicolussi","year":"2015","unstructured":"Nicolussi S, Gertsch J (2015) Endocannabinoid transport revisited. Vitam Horm 98:441\u2013485","journal-title":"Vitam Horm"},{"key":"1774_CR106","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.neuropharm.2005.04.014","volume":"49","author":"JM Oliva","year":"2005","unstructured":"Oliva JM et al (2005) Time course of opioid and cannabinoid gene transcription alterations induced by repeated administration with fluoxetine in rat brain. Neuropharmacology 49:618\u2013626","journal-title":"Neuropharmacology"},{"key":"1774_CR107","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1159\/000100778","volume":"54","author":"ES Onaivi","year":"2006","unstructured":"Onaivi ES (2006) Neuropsychobiological evidence for the functional presence and expression of cannabinoid CB2 receptors in the brain. Neuropsychobiology 54:231\u2013246. https:\/\/doi.org\/10.1159\/000100778","journal-title":"Neuropsychobiology"},{"key":"1774_CR108","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1196\/annals.1432.036","volume":"1139","author":"ES Onaivi","year":"2008","unstructured":"Onaivi ES, Ishiguro H, Gong JP, Patel S, Meozzi PA, Myers L et al (2008) Functional expression of brain neuronal CB2 cannabinoid receptors are involved in the effects of drugs of abuse and in depression. Ann N Y Acad Sci 1139:434\u2013449","journal-title":"Ann N Y Acad Sci"},{"key":"1774_CR109","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1196\/annals.1369.052","volume":"1074","author":"ES Onaivi","year":"2006","unstructured":"Onaivi ES, Ishiguro H, Gong JP, Patel S, Perchuk A, Meozzi PA et al (2006) Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain. Ann N Y Acad Sci 1074:514\u2013536. https:\/\/doi.org\/10.1196\/annals.1369.052","journal-title":"Ann N Y Acad Sci"},{"key":"1774_CR110","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.brainres.2005.03.036","volume":"1046","author":"VC Oropeza","year":"2005","unstructured":"Oropeza VC et al (2005) Systemic administration of WIN 55, 212\u20132 increases norepinephrine release in the rat frontal cortex. Brain Res 1046:45\u201354","journal-title":"Brain Res"},{"key":"1774_CR111","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1111\/febs.12260","volume":"280","author":"P Pacher","year":"2013","unstructured":"Pacher P, Kunos G (2013) Modulating the endocannabinoid system in human health and disease-successes and failures. FEBS J 280:1918\u20131943. https:\/\/doi.org\/10.1111\/febs.12260","journal-title":"FEBS J"},{"key":"1774_CR112","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.expneurol.2010.03.018","volume":"224","author":"D Parolaro","year":"2010","unstructured":"Parolaro D, Realini N, Vigano D, Guidali C, Rubino T (2010) The endocannabinoid system and psychiatric disorders. Exp Neurol 224:3\u201314. https:\/\/doi.org\/10.1016\/j.expneurol.2010.03.018","journal-title":"Exp Neurol"},{"key":"1774_CR113","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/nrn4004","volume":"16","author":"LH Parsons","year":"2015","unstructured":"Parsons LH, Hurd YL (2015) Endocannabinoid signalling in reward and addiction. Nat Rev Neurosci 16:579\u2013594. https:\/\/doi.org\/10.1038\/nrn4004","journal-title":"Nat Rev Neurosci"},{"key":"1774_CR114","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0163-7258(97)82001-3","volume":"74","author":"RG Pertwee","year":"1997","unstructured":"Pertwee RG (1997) Pharmacology of cannabinoid CB1 and CB2 receptors. Pharmacol Ther 74:129\u2013180. https:\/\/doi.org\/10.1016\/S0163-7258(97)82001-3","journal-title":"Pharmacol Ther"},{"key":"1774_CR115","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1017\/S0029665113003649","volume":"73","author":"RG Pertwee","year":"2014","unstructured":"Pertwee RG (2014) Elevating endocannabinoid levels: pharmacological strategies and potential therapeutic applications. Proc Nutr Soc 73:96\u2013105","journal-title":"Proc Nutr Soc"},{"key":"1774_CR116","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1054\/plef.2001.0341","volume":"66","author":"RG Pertwee","year":"2002","unstructured":"Pertwee RG, Ross RA (2002) Cannabinoid receptors and their ligands. Prostaglandins Leukot Essent Fatty Acids 66:101\u2013121. https:\/\/doi.org\/10.1054\/plef.2001.0341","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"1774_CR117","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1038\/nrn1247","volume":"4","author":"D Piomelli","year":"2003","unstructured":"Piomelli D (2003) The molecular logic of endocannabinoid signaling. Nat Rev Neurosci 4:873\u2013884. https:\/\/doi.org\/10.1038\/nrn1247","journal-title":"Nat Rev Neurosci"},{"key":"1774_CR118","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S0006-8993(02)03055-X","volume":"948","author":"M Pistis","year":"2002","unstructured":"Pistis M (2002) D9-tetrahydrocannabinol decreases extracellular GABA and increases extracellular glutamate and dopamine levels in the rat prefrontal cortex: an in vivo microdialysis stud. Brain Res 948:155\u2013158","journal-title":"Brain Res"},{"key":"1774_CR119","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1093\/alcalc\/agh110","volume":"40","author":"F Rodriguez de Fonseca","year":"2005","unstructured":"Rodriguez de Fonseca F, Del Arco I, Bermudez-Silva FJ, Bilbao A, Cippitelli A, Navarro M (2005) The endocannabinoid system: physiology and pharmacology. Alcohol Alcohol 40:2\u201314. https:\/\/doi.org\/10.1093\/alcalc\/agh110","journal-title":"Alcohol Alcohol"},{"key":"1774_CR120","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1111\/j.1471-4159.2009.05898.x","volume":"108","author":"A Rodriguez-Gaztelumendi","year":"2009","unstructured":"Rodriguez-Gaztelumendi A, Rojo ML, Pazos A, Diaz A (2009) Altered CB receptor-signaling in prefrontal cortex from an animal model of depression is reversed by chronic fluoxetine. J Neurochem 108:1423\u20131433","journal-title":"J Neurochem"},{"key":"1774_CR121","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.neuropharm.2019.02.026","volume":"149","author":"P Romero-Sanchiz","year":"2019","unstructured":"Romero-Sanchiz P, Nogueira-Arjona R, Pastor A, Araos P, Serrano A, Boronat A et al (2019) Plasma concentrations of oleoylethanolamide in a primary care sample of depressed patients are increased in those treated with selective serotonin reuptake inhibitor-type antidepressants. Neuropharmacology 149:212\u2013220. https:\/\/doi.org\/10.1016\/j.neuropharm.2019.02.026","journal-title":"Neuropharmacology"},{"key":"1774_CR122","doi-asserted-by":"publisher","first-page":"7284","DOI":"10.1523\/JNEUROSCI.5346-07.2008","volume":"28","author":"S Rossi","year":"2008","unstructured":"Rossi S, De Chiara V, Musella A, Kusayanagi H, Mataluni G, Bernardi G et al (2008) Chronic psychoemotional stress impairs cannabinoid-receptormediated control of GABA transmission in the striatum. J Neurosci 28:7284\u20137292. https:\/\/doi.org\/10.1523\/JNEUROSCI.5346-07.2008","journal-title":"J Neurosci"},{"key":"1774_CR123","first-page":"165","volume":"61","author":"M Rutkowska","year":"2004","unstructured":"Rutkowska M, Jachimczuk O (2004) Antidepressant\u2014like properties of ACEA (arachidonyl- 2-chloroethylamide), the selective agonist of CB1 receptors. Acta Pol Pharm 61:165\u2013167","journal-title":"Acta Pol Pharm"},{"key":"1774_CR124","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1176\/ajp.122.5.509","volume":"122","author":"JJ Schildkraut","year":"1965","unstructured":"Schildkraut JJ (1965) The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am J Psychiatry 122:509\u2013522","journal-title":"Am J Psychiatry"},{"key":"1774_CR125","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1097\/00008877-200312000-00001","volume":"14","author":"LP Shearman","year":"2003","unstructured":"Shearman LP et al (2003) Antidepressant-like and anorectic effects of the cannabinoid CB1 receptor inverse agonist AM251 in mice. Behav Pharmacol 14:573\u2013582","journal-title":"Behav Pharmacol"},{"key":"1774_CR126","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/sj.npp.1300335","volume":"29","author":"E Sibille","year":"2004","unstructured":"Sibille E et al (2004) Gene expression profilingof depression and suicide in human prefrontal cortex. Neuropsychopharmacology 29:351\u2013361","journal-title":"Neuropsychopharmacology"},{"key":"1774_CR127","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1006\/bbrc.1995.2437","volume":"215","author":"T Sugiura","year":"1995","unstructured":"Sugiura T, Kondo S, Sukagawa A, Nakane S, Shinoda A, Itoh K et al (1995) 2-Arachidonoylglycerol: A possible endogenous cannabinoid receptor ligand in brain. Biochem Biophys Res Commun 215:89\u201397","journal-title":"Biochem Biophys Res Commun"},{"key":"1774_CR128","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1006\/bbrc.1996.0020","volume":"218","author":"T Sugiura","year":"1996","unstructured":"Sugiura T, Kondo S, Sukagawa A, Tonegawa T, Nakane S, Yamashita A, Waku K (1996) Enzymatic synthesis of anandamide, an endogenous cannabinoid receptor ligand, through N-acylphosphatidylethanolamine pathway in testis: Involvement of Ca(2+)-dependent transacylase and phosphodiesterase activities. Biochem Biophys Res Commun 218:113\u2013117","journal-title":"Biochem Biophys Res Commun"},{"key":"1774_CR129","doi-asserted-by":"publisher","unstructured":"Tabiova V, Micale K, Kucerova J, Drago F (2015) Role of the Endocannabinoid System in Depression: from Preclinical to Clinical Evidence, In: Campolongo P., Fattore L. (eds) Cannabinoid Modulation of Emotion, Memory, and Motivation. Springer, New York, NY. https:\/\/doi.org\/10.1007\/978-1-4939-2294-9_5.","DOI":"10.1007\/978-1-4939-2294-9_5"},{"key":"1774_CR130","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1111\/ejn.12561","volume":"40","author":"ALB Terzian","year":"2014","unstructured":"Terzian ALB, Micale V, Wotjak CT (2014) Cannabinoid receptor type 1 receptors on GABAergic vs. glutamatergic neurons differentially gate sex-dependent social interest in mice. Eur J Neurosci 40:2293\u20132298","journal-title":"Eur J Neurosci"},{"key":"1774_CR131","doi-asserted-by":"publisher","unstructured":"Toczek M, Malinowska B (2017) Enhanced endocannabinoid tone as a potential target of pharmacotherapy. Lfs.\u00a0https:\/\/doi.org\/10.1016\/j.lfs.2018.04.054.","DOI":"10.1016\/j.lfs.2018.04.054"},{"key":"1774_CR132","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/S0083-6729(09)81015-7","volume":"81","author":"A Toth","year":"2009","unstructured":"Toth A, Blumberg PM, Boczan J (2009) Anandamide and the vanilloid receptor (TRPV1). Vitam Horm 81:389\u2013419. https:\/\/doi.org\/10.1016\/S0083-6729(09)81015-7","journal-title":"Vitam Horm"},{"key":"1774_CR133","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1002\/cbdv.200790159","volume":"4","author":"K Tsuboi","year":"2007","unstructured":"Tsuboi K, Takezaki N, Ueda N (2007) The N-acylethanolamine-hydrolyzing acid amidase (NAAA). Chem Biodivers 4:1914\u20131925","journal-title":"Chem Biodivers"},{"key":"1774_CR134","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/sj.bjp.0705100","volume":"138","author":"ET Tzavara","year":"2003","unstructured":"Tzavara ET et al (2003) The CB1 receptor antagonist SR141716A selectively increases monoaminergic neurotransmission in the medial prefrontal cortex: implications for therapeutic actions. Br J Pharmacol 138:544\u2013553","journal-title":"Br J Pharmacol"},{"key":"1774_CR135","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S0090-6980(02)00053-9","volume":"68\u201369","author":"N Ueda","year":"2002","unstructured":"Ueda N (2002) Endocannabinoid hydrolases. Prostaglandins Other Lipid Mediat 68\u201369:521\u2013534. https:\/\/doi.org\/10.1016\/S0090-6980(02)00053-9","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"1774_CR136","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.bbr.2011.04.031","volume":"223","author":"SN Umathe","year":"2011","unstructured":"Umathe SN, Manna SS, Jain NS (2011) Involvement of endocannabinoids in antidepressant and anti-compulsive effect of fluoxetine in mice. Behav Brain Res 223:125\u2013134","journal-title":"Behav Brain Res"},{"key":"1774_CR137","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.bbalip.2014.12.015","volume":"1851","author":"P Urquhart","year":"2015","unstructured":"Urquhart P, Nicolaou A, Woodward DF (2015) Endocannabinoids and their oxygenation by cyclo-oxygenases, lipoxygenases and other oxygenases. Biochim Biophys Acta 1851:366\u2013376","journal-title":"Biochim Biophys Acta"},{"key":"1774_CR138","doi-asserted-by":"publisher","first-page":"3709","DOI":"10.1021\/jm020818q","volume":"45","author":"M van der Stelt","year":"2002","unstructured":"van der Stelt M, van Kuik JA, Bari M, van Zadelhoff G, Leeflang BR, Veldink GA, Finazzi-Agro A et al (2002) Oxygenated metabolites of anandamide and 2-arachidonoylglycerol: Conformational analysis and interaction with cannabinoid receptors, membrane transporter, and fatty acid amide hydrolase. J Med Chem 45:3709\u20133720","journal-title":"J Med Chem"},{"key":"1774_CR139","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1126\/science.1115740","volume":"310","author":"MD Van Sickle","year":"2005","unstructured":"Van Sickle MD et al (2005) Identification and functional characterization of brainstem cannabinoid CB2 receptors. Science 310:329\u2013332","journal-title":"Science"},{"key":"1774_CR140","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/clpt.2011.296","volume":"91","author":"B Voleti","year":"2012","unstructured":"Voleti B, Duman RS (2012) The roles of neurotrophic factor and Wnt signaling in depression. Clin Pharmacol Ther 91:333\u2013338. https:\/\/doi.org\/10.1038\/clpt.2011.296","journal-title":"Clin Pharmacol Ther"},{"key":"1774_CR141","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/37371","volume":"390","author":"JA Wagner","year":"1997","unstructured":"Wagner JA, Varga K, Ellis EF, Rzigalinski BA, Martin BR, Kunos G (1997) Activation of peripheral CB1 cannabinoid receptors in haemorrhagic shock. Nature 390:518\u2013521. https:\/\/doi.org\/10.1038\/37371","journal-title":"Nature"},{"key":"1774_CR142","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/S0306-4522(03)00020-4","volume":"118","author":"X Wang","year":"2003","unstructured":"Wang X, Dow-Edwards D, Keller E, Hurd YL (2003) Preferential limbic expression of the cannabinoid receptor mRNA in the human fetal brain. Neuroscience 118:681\u2013694. https:\/\/doi.org\/10.1016\/S0306-4522(03)00020-4","journal-title":"Neuroscience"},{"key":"1774_CR143","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1126\/science.1063545","volume":"296","author":"RI Wilson","year":"2002","unstructured":"Wilson RI, Nicoll RA (2002) Endocannabinoid signaling in the brain. Science 296:678\u2013682. https:\/\/doi.org\/10.1126\/science.1063545","journal-title":"Science"},{"key":"1774_CR144","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.tips.2005.10.006","volume":"26","author":"JM Witkin","year":"2005","unstructured":"Witkin JM et al (2005) A therapeutic role for cannabinoid CB1 receptor antagonists in major depressive disorders. Trends Pharmacol Sci 26:609\u2013617","journal-title":"Trends Pharmacol Sci"},{"key":"1774_CR145","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.euroneuro.2011.07.018","volume":"21","author":"HU Wittchen","year":"2011","unstructured":"Wittchen HU, Jacobi F, Rehm J, Gustavsson A, Svensson M, Jonsson B et al (2011) The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharmacol 21:655\u2013679. https:\/\/doi.org\/10.1016\/j.euroneuro.2011.07.018","journal-title":"Eur Neuropsychopharmacol"},{"key":"1774_CR146","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.pnpbp.2003.11.005","volume":"28","author":"K Zavitsanou","year":"2004","unstructured":"Zavitsanou K et al (2004) Selective antagonist [3H] SR141716A binding to CB1 receptors is increased in the anterior cingulate cortex in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 28:355\u2013360","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"1774_CR147","doi-asserted-by":"publisher","first-page":"E5007","DOI":"10.1073\/pnas.1413210111","volume":"111","author":"HY Zhang","year":"2014","unstructured":"Zhang HY, Gao M, Liu QR, Bi GH, Li X, Yang HJ et al (2014) Cannabinoid CB2 receptors modulate midbrain dopamine neuronal activity and dopamine related behavior in mice. Proc Natl Acad Sci U S A 111:E5007\u2013E5015. https:\/\/doi.org\/10.1073\/pnas.1413210111","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1774_CR148","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/S0083-6729(09)81012-1","volume":"81","author":"L Zhang","year":"2009","unstructured":"Zhang L, Xiong W (2009) Modulation of the Cys-loop ligand-gated ion channels by fatty acid and cannabinoids. Vitam Horm 81:315\u2013335. https:\/\/doi.org\/10.1016\/S0083-6729(09)81012-1","journal-title":"Vitam Horm"},{"key":"1774_CR149","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1038\/npp.2014.24","volume":"39","author":"P Zhong","year":"2014","unstructured":"Zhong P, Wang W, Pan B, Liu X, Zhang Z, Long JZ et al (2014) Monoacylglycerol lipase inhibition blocks chronic stress-induced depressive-like behaviors via activation of mTOR signaling. Neuropsychopharmacology 39:1763\u20131776","journal-title":"Neuropsychopharmacology"},{"key":"1774_CR150","doi-asserted-by":"publisher","first-page":"833","DOI":"10.3390\/ijms19030833","volume":"19","author":"S Zou","year":"2018","unstructured":"Zou S, Kumar U (2018) Cannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous System. Int J Mol Sci 19:833. https:\/\/doi.org\/10.3390\/ijms19030833","journal-title":"Int J Mol Sci"}],"container-title":["Journal of Molecular Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-020-01774-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12031-020-01774-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-020-01774-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,9]],"date-time":"2021-10-09T05:52:30Z","timestamp":1633758750000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12031-020-01774-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,20]]},"references-count":150,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["1774"],"URL":"https:\/\/doi.org\/10.1007\/s12031-020-01774-7","relation":{},"ISSN":["0895-8696","1559-1166"],"issn-type":[{"value":"0895-8696","type":"print"},{"value":"1559-1166","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,20]]},"assertion":[{"value":"17 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"All the authors have given consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}]}}